Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NRX Pharmaceuticals (NRXP) Return on Capital Employed (2024 - 2025)

NRX Pharmaceuticals (NRXP) has disclosed Return on Capital Employed for 2 consecutive years, with 1.11% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 7.0% to 1.11% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.11% through Dec 2025, up 7.0% year-over-year, with the annual reading at 0.8% for FY2025, N/A changed from the prior year.
  • Return on Capital Employed for Q4 2025 was 1.11% at NRX Pharmaceuticals, up from 0.46% in the prior quarter.
  • The five-year high for Return on Capital Employed was 1.11% in Q4 2025, with the low at 0.38% in Q2 2025.